Cytek Biosciences
CTKB
$6.22
Share price
0.32%
Change (1 day)
-47.64%
Change (1 year)
Categories
P/S ratio for Cytek Biosciences (CTKB)
P/S ratio as of May 2024 (TTM): 4.22
According to Cytek Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.21646. At the end of 2023 the company had a P/S ratio of 6.40.
P/S ratio history for Cytek Biosciences from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.40 | -23.69% |
| 2022 | 8.39 | -50.8% |
| 2021 | 17.1 |